Sree Rayalaseema Hi-Strength Hypo Limited
Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Commodity Chemicals
srhhl.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Stock price
₹498.20
Market cap
856 Cr
Stock P/E
9.3
P/B
0.86
Dividend yield
0.6%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 226 Cr | 215 Cr | 165 Cr | 169 Cr | 170 Cr | 138 Cr | 160 Cr | 180 Cr | 182 Cr | 141 Cr | 163 Cr | 211 Cr |
| Operating expenses (approx.) | 199 Cr | 192 Cr | 138 Cr | 143 Cr | 141 Cr | 119 Cr | 143 Cr | 152 Cr | 155 Cr | 121 Cr | 150 Cr | 181 Cr |
| EBITDA | 26 Cr | 22 Cr | 27 Cr | 26 Cr | 29 Cr | 20 Cr | 18 Cr | 28 Cr | 27 Cr | 20 Cr | 13 Cr | 30 Cr |
| OPM % | 11.6% | 10.3% | 16.4% | 15.2% | 17.0% | 14.3% | 11.0% | 15.5% | 14.8% | 14.4% | 8.1% | 14.2% |
| Other income | 2 Cr | 10 Cr | 9 Cr | 2 Cr | 9 Cr | 13 Cr | 15 Cr | 10 Cr | 7 Cr | 19 Cr | 18 Cr | 10 Cr |
| Interest | 0.65 Cr | 0.62 Cr | 2 Cr | 0.61 Cr | 0.32 Cr | 0.37 Cr | 0.69 Cr | 0.42 Cr | 0.42 Cr | 0.41 Cr | 0.42 Cr | 0.50 Cr |
| Depreciation | 3 Cr | 3 Cr | 3 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr |
| Profit before tax | 25 Cr | 23 Cr | 26 Cr | 26 Cr | 36 Cr | 30 Cr | 27 Cr | 31 Cr | 32 Cr | 34 Cr | 23 Cr | 34 Cr |
| Tax % | 27.3% | 29.1% | 24.0% | 28.0% | 29.4% | 28.5% | 19.4% | 28.5% | 26.8% | 30.6% | 14.4% | 27.0% |
| Net profit | 18 Cr | 17 Cr | 20 Cr | 19 Cr | 25 Cr | 22 Cr | 22 Cr | 22 Cr | 23 Cr | 24 Cr | 20 Cr | 25 Cr |
| EPS (₹) | ₹10.77 | ₹9.69 | ₹11.39 | ₹10.85 | ₹14.74 | ₹12.56 | ₹12.81 | ₹13.06 | ₹13.57 | ₹14.16 | ₹11.83 | ₹14.53 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 689 Cr | 911 Cr | 1,267 Cr | 1,650 Cr | 866 Cr | 638 Cr | 667 Cr | Sign in for TTM |
| Operating expenses (approx.) | 589 Cr | 781 Cr | 1,119 Cr | 1,472 Cr | 755 Cr | 546 Cr | 578 Cr | Sign in for TTM |
| EBITDA | 100 Cr | 130 Cr | 149 Cr | 178 Cr | 111 Cr | 92 Cr | 88 Cr | Sign in for TTM |
| OPM % | 14.6% | 14.3% | 11.7% | 10.8% | 12.8% | 14.4% | 13.3% | Sign in for TTM |
| Other income | 4 Cr | 7 Cr | 11 Cr | 34 Cr | 22 Cr | 39 Cr | 55 Cr | Sign in for TTM |
| Interest | 9 Cr | 5 Cr | 3 Cr | 2 Cr | 4 Cr | 2 Cr | 2 Cr | Sign in for TTM |
| Depreciation | 50 Cr | 51 Cr | 19 Cr | 19 Cr | 11 Cr | 7 Cr | 7 Cr | Sign in for TTM |
| Profit before tax | 45 Cr | 81 Cr | 137 Cr | 190 Cr | 107 Cr | 119 Cr | 121 Cr | Sign in for TTM |
| Tax % | 16.6% | 25.1% | 25.0% | 19.0% | 26.4% | 26.6% | 25.4% | Sign in for TTM |
| Net profit | 38 Cr | 61 Cr | 103 Cr | 154 Cr | 79 Cr | 87 Cr | 90 Cr | Sign in for TTM |
| EPS (₹) | ₹22.08 | ₹35.29 | ₹59.88 | ₹89.87 | ₹46.01 | ₹50.96 | ₹53.24 | Sign in for TTM |
| Dividend payout % | — | — | 5.0% | 3.9% | 8.7% | 5.9% | 5.7% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 17 Cr | 17 Cr | 17 Cr | 17 Cr | 17 Cr | 17 Cr | 17 Cr |
| Reserves | 294 Cr | 371 Cr | 553 Cr | 734 Cr | 783 Cr | 902 Cr | 954 Cr |
| Borrowings | 40 Cr | — | — | 12 Cr | 8 Cr | 14 Cr | 0.39 Cr |
| Other liabilities | 94 Cr | 131 Cr | 217 Cr | 160 Cr | 101 Cr | 122 Cr | 131 Cr |
| Total liabilities | 445 Cr | 519 Cr | 787 Cr | 923 Cr | 909 Cr | 1,071 Cr | 1,115 Cr |
| Fixed assets (net) | 138 Cr | — | — | 102 Cr | 119 Cr | 129 Cr | 87 Cr |
| CWIP | 3 Cr | — | — | 14 Cr | 0 Cr | 0 Cr | 0 Cr |
| Investments | 42 Cr | — | — | 216 Cr | 261 Cr | 357 Cr | 351 Cr |
| Loans & advances | 0.83 Cr | — | — | 0.96 Cr | 26 Cr | 26 Cr | 29 Cr |
| Inventories | 37 Cr | — | — | 126 Cr | 32 Cr | 40 Cr | 50 Cr |
| Trade receivables | 82 Cr | — | — | 149 Cr | 107 Cr | 103 Cr | 84 Cr |
| Cash & bank | 42 Cr | — | — | 27 Cr | 15 Cr | 369 Cr | 434 Cr |
| Other assets | 101 Cr | 519 Cr | 787 Cr | 288 Cr | 350 Cr | 47 Cr | 80 Cr |
| Total assets | 445 Cr | 519 Cr | 787 Cr | 923 Cr | 909 Cr | 1,071 Cr | 1,115 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | 60 Cr | 141 Cr | 139 Cr | 65 Cr | 39 Cr |
| Cash from investing | — | — | -1 Cr | -112 Cr | -133 Cr | -8 Cr | 37 Cr |
| Cash from financing | — | — | -51 Cr | -17 Cr | -17 Cr | -17 Cr | -11 Cr |
| Net cash flow | — | — | 7 Cr | 13 Cr | -12 Cr | 40 Cr | 65 Cr |
| Free cash flow (OCF − Capex) | — | — | 45 Cr | 132 Cr | 119 Cr | 63 Cr | 33 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | 17.4% | 22.2% | 24.6% | 25.2% | 13.8% | 12.8% | 12.4% |
| ROE % | 0.0% | 15.6% | 18.0% | 20.5% | 9.9% | 9.4% | 9.2% |
| Debtor days | 43 | — | — | 33 | 45 | 59 | 46 |
| Inventory days | 39 | — | — | 80 | 29 | 42 | 55 |
| Days payable | 27 | — | — | 45 | 12 | 15 | 13 |
| Cash conversion cycle | 56 | — | — | 68 | 62 | 86 | 88 |
| Debt / equity | 0.13 | — | — | 0.02 | 0.01 | 0.02 | 0.0004 |
| Current ratio | 2.15 | — | — | 3.66 | 10.56 | 8.99 | 10.51 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | -0.08 | -0.06 | -3.85 | -4.90 |
Compare with peers
Loading peers…